Tarsus Pharmaceuticals In... (TARS)
NASDAQ: TARS
· Real-Time Price · USD
54.85
0.71 (1.31%)
At close: Aug 15, 2025, 12:25 PM
13F Institute Ownership
Total Institutes of 190 in Tarsus Pharmaceuticals reduced their positions with a decrease of 10 investors compared to the previous quarter. An additional 2.9M shares, as total invested capital declined by $11.76M with ownership percentage increasing from 104.89% to 109.69%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.382
0.38
Call Flow 19,900
72%
Put Flow 7,600
28%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Rtw Investments, LP | 8.43% | 3.32M | +2.46% | 170.34M | 2.61% | May 15, 2025 |
| Blackrock, Inc. | 8.02% | 3.15M | -10.88% | 162.01M | < 0.01% | May 02, 2025 |
| Paradigm Biocapital Advisors L... | 6.63% | 2.61M | +3.09% | 134.09M | 6.14% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.